Kincaid IQ

Kincaid IQ

McKinsey + Bain KPIs with Evidence Receipts. Verified or it's not real.
Status: LIVE • 3 live events
EBITDA / Risk Feed
Portfolio MTD: Cost Trend +11.8% | Contract Compliance 94.8% | Benefits NPS +38McKinsey Alert: YoY PMPM exceeds baseline by 280bps | $4.8M EBITDA at riskContract Leakage: $2.1M recovery opportunity identified in Q4 vendor reconciliationPortfolio MTD: Cost Trend +11.8% | Contract Compliance 94.8% | Benefits NPS +38McKinsey Alert: YoY PMPM exceeds baseline by 280bps | $4.8M EBITDA at riskContract Leakage: $2.1M recovery opportunity identified in Q4 vendor reconciliation

Financial Risk & EBITDA Protection

McKinsey Framework
Cost Trend Stress Index
McKinsey
118
+18pp
YoY PMPM vs McKinsey Baseline
Details →
Q1TrendQ4
Contract Value Leakage Rate
McKinsey
3.2%
+1.7pp
Off-contract + Pricing Variance
Details →
Q1TrendQ4
Contract Compliance Rate
McKinsey
94.8%
-3.2pp
Contract Terms Adherence
Details →
Q1TrendQ4
Contract Ambiguity Risk Score
McKinsey
42
+17pts
High-spend Contract Clarity
Details →
Q1TrendQ4

Live Event Stream

Real-time healthcare cost & compliance events
1 Critical
2 High
|
3 McKinsey
0 Bain
CRITICALCost Trend•0s ago
McKinsey
YoY PMPM Trend Exceeds McKinsey Baseline
Net PMPM trend reached 11.8%, 280bps above McKinsey commercial baseline (9-10%).
Impact: $4.8M annualized EBITDA at risk
KPI: Cost Trend Stress Index
HIGHContract•2m ago
McKinsey
Contract Value Leakage Detected
Off-contract spend + pricing misses identified in Q4 vendor reconciliation.
Impact: $2.1M recoverable EBITDA
KPI: Contract Value Leakage Rate
HIGHPharmacy•4m ago
McKinsey
Pharmacy Rebate Discrepancy Alert
Opaque reimbursement terms flagged in specialty pharmacy contracts.
Impact: $1.3M annual exposure
KPI: Pharmacy Reimbursement Exposure